Inmode Ltd (INMD) Stock Price, Quote & News

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well a...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 4 909 6313

Website: www.inmodemd.com

Address:

Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel

Paardaam Dec. 5 at 4:38 PM

$INMD what a disappointment!!!!

0 · Reply

SuperGreenToday Dec. 3 at 6:51 PM

$INMD Share Price: $14.40 Contract Selected: May 15, 2026 $15 Calls Buy Zone: $1.02 – $1.26 Target Zone: $1.66 – $2.03 Potential Upside: 54% ROI Time to Expiration: 162 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

romroc25 Nov. 25 at 12:19 AM

$INMD Mo She needs to grow a pair.

0 · Reply

findingthestock Nov. 24 at 9:00 PM

$INMD DOMA must ask change in management with Moshe now saying there will no buybacks and there is no acquisition to be made https://www.investing.com/news/transcripts/inmode-at-jefferies-london-strategic-growth-amidst-challenges-93CH-4365928

0 · Reply

Shortsnightmare Nov. 24 at 5:17 PM

$INMD The company has now beat two quarters in a row and its consumables businesses, the canary in the coal mine, just jumped +26 pct in thelast quarter. It ALWAYS leads equipment sales. Great SMID cap value play with upward torque to a stronger US consumer and lower interest rates in 2026. Huge upside potential. Extremely limited downside due to strong profitability, zero debt and massive cash position.

0 · Reply

Shortsnightmare Nov. 24 at 5:13 PM

$INMD Strong Buy. Privatization candidate. The business is improving after 2 years of downturn due to interest rates. Super strong balance sheet. Super strong FCF. Super cheap! $45 stock.

0 · Reply

findingthestock Nov. 24 at 3:05 PM

$INMD MOSHE WILL NOT DO ANY MORE BUYBACKS OR DIVIDENDS stock price decline no shareholder return value

1 · Reply

Shortsnightmare Nov. 18 at 10:15 PM

$INMD The CEO presented at Jefferies conference in the UK today and mentioned he is starting to see encouraging trends. First time in a long time he has indicated this….webcast is posted under their IR section.

0 · Reply

findingthestock Nov. 18 at 4:41 AM

$INMD

0 · Reply

romroc25 Nov. 17 at 10:59 PM

$INMD fire moshe.

0 · Reply

InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

Nov 3, 2025, 8:05 AM EST - 4 weeks ago

InMode Appoints Michael Dennison as President of North America

Oct 30, 2025, 8:30 AM EDT - 5 weeks ago

InMode to Participate in Upcoming Investor Conferences

Oct 27, 2025, 2:07 PM EDT - 5 weeks ago

InMode: Discounted Valuation & Strong Fundamentals Make It A Buy

Oct 9, 2025, 7:00 AM EDT - 2 months ago

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

Sep 9, 2025, 8:15 AM EDT - 3 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

Sep 2, 2025, 8:30 AM EDT - 3 months ago

InMode to Present at Baird 2025 Global Healthcare Conference

Jul 30, 2025, 3:22 PM EDT - 4 months ago

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:00 AM EDT - 4 months ago

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

Jul 12, 2025, 8:08 AM EDT - 5 months ago

InMode: Margin Pressure, But Optionality Makes It Worth A Look

Jul 10, 2025, 7:00 AM EDT - 5 months ago

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

May 28, 2025, 8:30 AM EDT - 6 months ago

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 9, 2025, 8:22 AM EDT - 7 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

May 7, 2025, 8:30 AM EDT - 7 months ago

InMode to Present at Upcoming Investor Conferences and Events

May 6, 2025, 8:03 AM EDT - 7 months ago

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

Apr 29, 2025, 7:00 AM EDT - 7 months ago

InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)

Apr 29, 2025, 1:52 AM EDT - 7 months ago

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Apr 28, 2025, 1:41 PM EDT - 7 months ago

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

Apr 28, 2025, 11:53 AM EDT - 7 months ago

InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 7:00 AM EDT - 7 months ago

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

Apr 3, 2025, 4:26 AM EDT - 8 months ago

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

Mar 26, 2025, 8:30 AM EDT - 9 months ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 6, 2025, 7:30 AM EST - 9 months ago

InMode Responds to Doma Perpetual's Letters

Mar 3, 2025, 8:30 AM EST - 9 months ago

InMode to Present at Upcoming Investor Conferences

Feb 10, 2025, 1:14 AM EST - 10 months ago

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Feb 6, 2025, 9:08 AM EST - 10 months ago

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

Feb 4, 2025, 7:00 AM EST - 10 months ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 3, 2025, 8:30 AM EST - 10 months ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Jan 28, 2025, 9:32 AM EST - 11 months ago

InMode: A Clear Bargain With Unique Risks

Jan 16, 2025, 7:00 AM EST - 11 months ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 15, 2025, 8:05 AM EST - 11 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 10, 2025, 6:07 AM EST - 11 months ago

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Jan 8, 2025, 7:00 AM EST - 11 months ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Dec 12, 2024, 1:17 AM EST - 1 year ago

InMode: Product Origination And Undervaluation Make The Stock A Buy

Nov 5, 2024, 9:43 AM EST - 1 year ago

InMode: $25/Share Is Closer Than You Think

Oct 31, 2024, 12:16 PM EDT - 1 year ago

InMode: A Deep Dive After Q3 Earnings

Oct 30, 2024, 11:33 AM EDT - 1 year ago

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 24, 2024, 7:03 AM EDT - 1 year ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 10, 2024, 7:00 AM EDT - 1 year ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Oct 1, 2024, 7:00 AM EDT - 1 year ago

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

Sep 19, 2024, 7:14 AM EDT - 1 year ago

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

Sep 10, 2024, 7:00 AM EDT - 1 year ago

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

Sep 6, 2024, 4:38 AM EDT - 1 year ago

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

Sep 4, 2024, 8:30 AM EDT - 1 year ago

InMode to Present at 2024 Baird Global Healthcare Conference

Aug 1, 2024, 3:34 PM EDT - 1 year ago

InMode Ltd. Revenue, Profit Plunge

Aug 1, 2024, 11:19 AM EDT - 1 year ago

InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

Paardaam Dec. 5 at 4:38 PM

$INMD what a disappointment!!!!

0 · Reply

SuperGreenToday Dec. 3 at 6:51 PM

0 · Reply

romroc25 Nov. 25 at 12:19 AM

$INMD Mo She needs to grow a pair.

0 · Reply

findingthestock Nov. 24 at 9:00 PM

0 · Reply

Shortsnightmare Nov. 24 at 5:17 PM

0 · Reply

Shortsnightmare Nov. 24 at 5:13 PM

$INMD Strong Buy. Privatization candidate. The business is improving after 2 years of downturn due to interest rates. Super strong balance sheet. Super strong FCF. Super cheap! $45 stock.

0 · Reply

findingthestock Nov. 24 at 3:05 PM

$INMD MOSHE WILL NOT DO ANY MORE BUYBACKS OR DIVIDENDS stock price decline no shareholder return value

1 · Reply

Shortsnightmare Nov. 18 at 10:15 PM

0 · Reply

findingthestock Nov. 18 at 4:41 AM

$INMD

0 · Reply

romroc25 Nov. 17 at 10:59 PM

$INMD fire moshe.

0 · Reply

findingthestock Nov. 17 at 3:13 PM

$INMD Unfortunately this stock continues to decline and no positive catalyst on the horizon and Moshe and management continue to paint a grim picture With low share price you would have thought more buying and buyback from the company That hasn’t been the case and the street likely put this as a hold or sell with price decling

0 · Reply

findingthestock Nov. 14 at 4:49 PM

$INMD with Moshe and he will say not enough federal interest cuts their product sales will decline and well the stock price from 90s to now heading to 10

0 · Reply

romroc25 Nov. 11 at 10:07 PM

$INMD Any way Mosche can take a buy out?

0 · Reply

findingthestock Nov. 7 at 3:05 AM

$INMD can’t blame you management has let down investors and I thought maybe maybe it could get to $20 but doesn’t look like it this may be go to $10 or less and shorted to hell

1 · Reply

vk1234d Nov. 6 at 8:30 PM

$INMD I am done with it.All the very best to all the longs here.

0 · Reply

JarvisFlow Nov. 6 at 6:42 PM

UBS updates rating for InMode ( $INMD ) to Neutral, target set at 16.25 → 16.

0 · Reply

Estimize Nov. 5 at 11:06 PM

$INMD reported 0.38 EPS and 93.17 revenue for Q3. http://www.estimize.com/intro/inmd?chart=historical&metric_name=eps&utm_content=INMD&utm_

0 · Reply

findingthestock Nov. 5 at 5:49 PM

$INMD What kind of management keeps repeating such doomsday sentiment So let’s understand this, we’ve had multiple federal interest rate cuts and they keep repeating not good enough and no light at end of tunnel Unless interest is like at 1% Moshe will keep repeating this line It’s getting apparent, in North America Inmode devices will not exceed expectations and sales. Practitioners are not buying It’s been 3 years now same excuses

1 · Reply

findingthestock Nov. 5 at 5:10 PM

$INMD Nothing about buybacks or dividends I except DOMA issue another letter and for management to be changed I would love this stock to get back to 20 but nothing from this call looked optimistic And they didn’t want to talk about 2026 and guidance so that’s not good so either they are expecting number to remain same or go down

1 · Reply

findingthestock Nov. 5 at 3:23 PM

$INMD Moshe Mizrahy, CEO, InMode: No, what I wanted to say, it's not just in the United States. We don't see the light at the end of the tunnel as we go to financing capital equipment, especially medical equipment to clinics. I'm not talking about hospital. In hospital, it's probably different. As far as clinics were buying capital equipment like for medical aesthetic or any other medical community, I mean, the interest rate on leasing are still very high. I know that the interest rate went down twice in the United States, half a percent. In Europe, it has not yet. We believe that sometime in 2026, when the U.S. will lead the reduction of interest rates, it will come up to other territories, but we don't see it yet. https://www.investing.com/news/transcripts/earnings-call-transcript-inmode-q3-2025-beats-expectations-stock-rises-93CH-4334028

0 · Reply

findingthestock Nov. 5 at 2:52 PM

$INMD Stock is sinking after Moshe disastrous call and outlook when you think it’s a good time to buy, a dip…it just keeps going down because of Moshe

0 · Reply

findingthestock Nov. 5 at 1:40 PM

$INMD What are they doing with cash Buybacks? Dividends? Acquisition? Been invested in this stock for years and nothing has changed with Moshe Will wait to hear what he says on the call

1 · Reply

Market Cap	912.74M
Revenue (ttm)	394.82M
Net Income (ttm)	181.28M
EPS (ttm)	N/A
PE Ratio	10.17
Forward PE	N/A
Profit Margin	45.91%
Debt to Equity Ratio	0.00

Volume	389,569
Avg Vol	678,552
Day's Range	N/A - N/A
Shares Out	63.21M
Stochastic %K	74%
Beta	2.14
Analysts	Sell
Price Target	$16.80